BLTH AMERICAN BATTERY MATERIALS, INC. Insider Trading

Director Lipson purchases 800 shares across 3 transactions at $5.5K blended avg $6.87 amid 90d +73.3% rally; 5 of 5 prior BLTH buys achieved positive 90d returns.

Lipson Adam C (Director) executed 3 separate open-market purchases totaling 800 shares for $5,499.00 between 2025-03-27 and 2025-03-28 at a blended average price of $6.87. This acquisition occurs within a near-term momentum context: the stock has posted a 30-day change of +18.2% and a 90-day change of +73.3%, with the current price of $6.50 remaining -23.5% from the 52-week high of $8.50. Notably, Lipson's prior 5 open-market trades at BLTH all achieved positive 90-day returns, with his most recent December 2024 purchases showing 90d gains ranging from +533.3% to +1030.0%; this consistent timing pattern warrants attention against the backdrop of significant recent revenue contraction (-93.8% annual growth) and ongoing net losses ($-627,264.00 in the latest quarter). The purchase signals continuation of a demonstrated pattern of accumulation at this security, though the fundamental deterioration and unprofitable status merit independent verification of underlying catalysts.

10% owner Marilyn S. Kane sold 36,450 shares for $174,960, reducing holdings by 99.2% from 33,854 to 281 shares.

Marilyn S. Kane, a 10% owner, executed two separate sales totaling 36,450 shares for $174,960.00 at $4.80 per share on 2024-10-23 and 2025-02-03, while making a small concurrent purchase of 2,877 shares at $2.25. The net effect is a reduction of 33,573 shares, representing a -99.2% decrease in her holdings from 33,854 to 281 shares. This near-complete liquidation occurs in a company with severely depressed fundamentals: annual revenue growth of -93.8%, latest quarterly revenue of $49,773.00, a net loss of $-627,264.00, and a market cap of only $67,653.70. The combination of a majority shareholder divesting virtually her entire position while the company faces severe revenue contraction and ongoing losses suggests a material shift in her stake in the enterprise.

Director VORWERK JUSTIN J purchased 15,861 shares in 4 tranches from $0.01–$0.45; current price $5.25 (+57.7% 30-day).

VORWERK JUSTIN J acquired 15,861 shares in 4 separate purchases spanning May 2023 through October 2024, with transaction prices ranging from $0.01 to $0.45 and a blended average price of $0.39. The stock has since appreciated to $5.25, representing significant gains on the director's accumulated position. However, the underlying company shows severe financial deterioration: latest quarterly revenue stands at $49,773.00, annual revenue growth is -93.8%, and the company posted a full-year net income of $-627,264.00. The market cap of $62,642.31 suggests a micro-cap entity in financial distress. The pattern of multiple small purchases at progressively higher prices through late 2024, combined with extreme recent price momentum (+57.7% in 30 days, +238.7% in 90 days), warrants examination of whether the stock's rally reflects operational recovery or speculative move divorced from fundamentals.

Director Adam C Lipson bought 2,224 shares at blended average $1.35; stock up +307.4% in 90 days, company down -93.8% annual revenue.

Adam C Lipson, a Director, made 2 separate purchases totaling 2,224 shares for $3,002.40, increasing his holdings from 312,747 to 314,971 shares (+0.7%). The transactions occurred at prices of $2.40 (2023-05-22) and $0.30 (2024-05-22), producing a blended average of $1.35, well below the current price of $5.50. The stock has rallied +307.4% over the 90-day period preceding this filing, yet the company's fundamentals remain severely distressed: annual revenue contracted -93.8%, latest quarterly revenue stands at $49.8K, the market cap is only $65.6K, and the company posted a full-year net loss of $-627.3K. His cross-ticker track record shows 5 prior buys with an average 30-day return of +314.9%, but prior BLTH purchases lack measurable 90-day outcomes to assess timing discipline at this specific ticker. The combination of aggressive price-momentum gains, deteriorating revenue fundamentals, and extreme balance-sheet stress creates material tension between the buy signal and operational reality.

Director Lux Sebastian F bought 12,224 shares across 3 transactions (May 2023–Oct 2024) at $0.40 blended avg; holds 34,234 shares post-transaction.

Sebastian F, a director at American Battery Materials, made three separate purchases totaling 12,224 shares for $4,841.38, increasing his holdings by 55.5% from 22,010 to 34,234 shares. The transactions span over 17 months (May 2023 to October 2024) at progressively higher prices ($0.01, $0.30, $0.45), with the blended average price of $0.40 now sitting 55.0% below the current price of $5.50. However, the company's operational fundamentals remain deeply troubled: annual revenue contracted 93.8% year-over-year to $49,773.00 in the latest quarter, the company is unprofitable with a $-627,264.00 net loss, and market capitalization stands at only $65,625.28. The stock's 307.4% 90-day surge masks an underlying business in severe decline, and a director's incremental accumulation at these depressed historical prices does not address the structural revenue collapse or lack of profitability anchoring the valuation.

CEO Graber purchased 67,907 shares across 5 transactions for $32,493.03; holdings increased 63.3% to 175,251 shares amid revenue decline of -93.8% and negative net income of $-627,264.00.

Graber David Edward (Chief Executive Officer) executed 5 separate purchases totaling 67,907 shares for $32,493.03 between May 2023 and October 2024, at prices ranging from $0.30 to $2.34. This represents a 63.3% increase in his shareholdings to 175,251 shares. The accumulation occurs against deteriorating fundamentals: American Battery Materials reported quarterly revenue of $49,773.00 with net income of $-627,264.00, and annual revenue contracted by -93.8% year-over-year. The company's market cap of $65,625.28 and unprofitable operational status stand in sharp contrast to the CEO's continued capital deployment at the company. The stock has gained 65.2% over 30 days and 307.4% over 90 days from depressed levels, suggesting the timing aligns with recent price recovery rather than preceding it.

Director Jared I Levinthal acquired 5,084 shares over 3 transactions (blended avg $0.32) at unprofitable BLTH with -93.8% annual revenue decline and $39.7K market cap.

Jared I Levinthal, a Director, made 3 separate purchases totaling 5,084 shares for $1,628.38 (blended average price $0.32) across May 2023, May 2024, and October 2024, increasing his holdings from 200 shares to 5,284 shares (a +2542.0% increase). The company is unprofitable with a full fiscal year net loss of $-627,264.00, latest quarterly revenue of $49,773.00, and an annual revenue decline of -93.8%. The current price of $3.33 represents -33.4% from the 52-week high, though the stock is +2.5% over 90 days. The director's persistent acquisition pattern across three separate dates and escalating share prices ($0.01, $0.30, $0.45) stands out against a backdrop of financial deterioration and an extremely small market cap of $39,733.12. This repeated commitment to purchasing shares at progressively higher prices, combined with a substantial increase in ownership percentage, warrants investor scrutiny of the company's strategic position and why management sees sufficient value to continue accumulating despite the revenue contraction.

Director Glenn Dylan purchased 2,224 shares across 2 transactions ($0.01 and $0.30) at BLTH amid -93.8% revenue collapse.

Glenn Dylan, a Director, executed 2 purchases totaling 2,224 shares for $342.50 on 2023-05-22 and 2024-05-22, increasing his holdings by 38.3% to 8,029 shares. The blended average price of $0.15 is substantially below the current price of $3.33, though the stock has declined 33.4% from its 52-week high of $5.00 and 16.8% over the past 30 days. The company's financial condition is severely deteriorated: annual revenue growth is -93.8%, net income was $-627,264.00 over the most recent full fiscal year, and market cap stands at $39,733.12. The two purchases at dramatically different prices ($0.01 versus $0.30) do not form a clear pattern and occur across a one-year span, making it difficult to infer directional conviction from timing alone. Given the company's profitability crisis and revenue collapse, this insider accumulation warrants scrutiny regarding the basis for the director's continued investment.

Director White buys 2,000 shares of BLTH at $0.01; holdings rise to 2.5K shares, but company posts -93.8% revenue decline and $-627.3K annual loss.

White Patrick Joseph, a Director, purchased 2,000 shares at $0.01 on 2023-05-25, increasing his holdings by 386.1% to 2.5K shares. The transaction occurred at a price far below the current market price of $3.33 and the 52-week high of $5.00, though notably the stock is currently down 16.8% over 30 days. However, the company's fundamentals present a concerning backdrop: American Battery Materials reported revenue of $49.8K in its latest quarter with an annual revenue decline of -93.8% year-over-year, a net loss of $-627.3K, and a market cap of only $39.7K. The extremely low purchase price and de minimis transaction value ($14.00) combined with the company's severe financial deterioration suggest limited material significance to this filing, despite the large percentage increase in the director's position.

Director Suckling buys 11,112 shares in 2 tranches ($2.40 & $0.30) at depressed valuations; unprofitable company with -93.8% annual revenue decline

Andrew P. Suckling, a director at American Battery Materials, completed 2 separate purchases totaling 11,112 shares for $15,001.20, with per-transaction prices of $2.40 on 2023-05-22 and $0.30 on 2024-05-22. The company's fundamentals are severely distressed: latest quarterly revenue was $49,773.00, net income was $-627,264.00, annual revenue growth was -93.8%, and the company remains unprofitable on a full-year basis with a market cap of $59,659.34. The director's cumulative acquisition at a blended average price of $1.35 contrasts sharply with the current price of $5.00, which itself sits at -28.6% from the 52-week high of $7.00. This filing merits scrutiny given the extreme financial deterioration, near-zero market capitalization, and the unusual pricing pattern across the two tranches—particularly the purchase at $0.30 during a 90-day period showing +150.0% appreciation. Investors should evaluate whether this acquisition reflects board-level assessment of turnaround prospects or reflects other structural considerations in a shell-stage or recovery-stage entity.